C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
FORA Equity

FORA

OTCMKTS · FORA

$2.66
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
45/100 composite
Fundamentals52
Regulatory49
Market40
Editorial30
Composite · trailing 12 months

Forian Corporation has been assigned a Neutral rating within the current assessment band, reflecting composite scoring across varied sector metrics. The conviction level stands at a modest 2 out of 5, indicating a degree of uncertainty or mixed prospects. Among the contributing pillars, the fundamentals pillar shows relative strength but is moderated by Forian's stretched financial condition and negative net income. Regulatory and market scores reinforce the Neutral stance, with elements such as regulatory posture facing challenges typical within the US jurisdiction. Editorial coverage offers little influence due to low newsroom presence.

The underlying financial data portrays a company navigating moderate turbulence. Year-over-year revenue growth has contracted, reflecting various pressures that weigh on overall performance. A gross margin nearing 47% suggests operational efficiencies but is overshadowed by a concerning negative operating margin. While a market capitalization just below $68 million provides context to scale, there is significant stress from non-profitable operations, showcased by negative EBITDA. Regulatory indicators, such as enforcement events, display stability, yet cadence sees room for improvement, contributing to the regulatory pillar. In the realm of market signals, a lack of public market pricing data casts additional ambiguity into the mix.

Looking forward, the pivotal regulatory pillar could emerge as a primary lever for momentum should Forian enhance filing cadence and reformulate jurisdictional strategies. Monitoring any shifts in this area is crucial as regulatory clarity can act as a stabilizing force or a catalyst for favorable investor sentiment. With expected adjustments and requisite improvements on the regulatory front, Forian could tip its composite score towards a more favorable band within future assessments.

Scored: 2026-08-25Valid through: 2026-10-09Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
Corporate DetailsCompany profile
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$67.8M
Enterprise value
$36.3M
PEG ratio
0.94
Price to book
2.28
Price to sales
2.26
EV / EBITDA
20.05
Revenue (TTM)
$30.1M
Gross profit (TTM)
$14.2M
EBITDA
$-5.6M
Operating margin
-50.9%
Profit margin
-17.0%
Rev growth YoY
-2.9%
Return on equity
-17.9%
Return on assets
-8.4%
EPS (TTM)
$-0.09
EPS est. current year
$0.09
Wall St. target price
$2.10
Shares outstanding
31.2M
Insider ownership
51.8%
Institutional ownership
14.9%
Beta
0.93
Full-time employees
50
GICS sector
Healthcare
GICS industry
Health Information Services
Filings & DisclosuresPrimary sources
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for FORA (FORA)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for FORA (FORA), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for FORA are maintained by Cannabis Investor News and refreshed throughout the trading day.